ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2008
[Problems in the treatment of upper rectal carcinoma].
Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread.Techniques in coloproctology · 2023Pooled it
- Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87.Langenbeck's archives of surgery · 2015Trial
- Quality of life and functional outcomes after low anterior rectal resection with total mesorectal excision: a propensity score-matched comparison of robotic-assisted versus open surgery.Langenbeck's archives of surgery · 2026Article
- Management of the adenocarcinoma of the upper rectum: a reappraisal.Updates in surgery · 2021Review
- Is it possible to give a single definition of the rectosigmoid junction?Surgical and radiologic anatomy : SRA · 2018Review
- Factors Influencing Oncologic Outcomes after Tumor-specific Mesorectal Excision for Rectal Cancer.Journal of the Korean Society of Coloproctology · 2012Article
- [Neoadjuvant radiochemotherapy for rectal cancer].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the literature there is some disagreement about the treatment of upper rectal carcinoma (aboral margin 12-16 cm from the anocutaneous line), in particular about the necessary extent of mesorectal excision and the indications for neoadjuvant and adjuvant therapy. The special pathologic features of upper rectal carcinomas (lymphatic spread, distal tumor spread beyond the gross margin) and present clinical experiences are discussed. From it result the following recommendations: partial mesorectal excision, neoadjuvant radiochemotherapy for cT4 tumors only; adjuvant radiochemotherapy in case of intraoperative tumor perforation or incision into/through tumor, incomplete partial mesorectal excision or tumor positive circumferential resection margin (CRM); adjuvant chemotherapy in case of histologically confirmed regional lymph node metastases.
Indexed as
Identifiers
18274715What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.